AGIO
Companies
NASDAQ
Agios Pharmaceuticals Inc.
Health Care
$35.50
+$2.63 (+8.02%)
Price Chart
Overview
About AGIO
Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.
Market Cap
$2.7B
Volume
22.7M
Avg. Volume
25.1M
P/E Ratio
-4.2713814
Dividend Yield
0.00%
Employees
634.0
Company Information
Risk & Correlation Analysis
Market Correlation
1.42
High Correlation
Volatility
High (0.56)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
Low Sensitivity
GDP Growth
Medium Sensitivity
Liquidity
Low Sensitivity
Commodity Prices
Low Sensitivity
Credit Quality
Medium Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, AGIO shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$2.7B
Volume22.7M
P/E Ratio-4.27
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 13, 2025Related Securities
Pricing info last updated June 17, 2025 (after market close)Other info last updated April 2, 2025